Daily Stock List
American Petro-Hunter, Inc. (AAPH)
The Stock Brainiac, StockRockandRoll, Otcstockexchange, Stock Edge, WallStreetGrand, WhisperFromWallStreet, Lebed.biz, and Stock exploder reported earlier on American Petro-Hunter, Inc. (AAPH), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
American Petro-Hunter, Inc. is an oil and natural gas exploration and production (E&P) company with current projects in Kansas and Oklahoma. The Company established on January 24, 1996 pursuant to the laws of the State of Nevada under the name Wolf Exploration, Inc. In August 2001, they changed their name to American Petro-Hunter, Inc. and started focusing their business on the exploration and eventual exploitation of oil and gas. American Petro-Hunter has their headquarters in Scottsdale, Arizona.
As of May 15, 2012, the Company has two producing wells in Kansas and five producing wells in Oklahoma. In addition, they have rights for the exploration and production of oil and gas on an aggregate of approximately 6,230 acres in those states. This includes the Company's core assets with rights to explore on 2,000 acres in Oklahoma, near the town of Ripley on the North Oklahoma Mississippi Project and a 40 percent working interest in 3,000 acres in south-central Oklahoma (the South Oklahoma Lease).
American Petro-Hunter's crude oil production sells to N.C.R.A. in MacPherson, Kansas and Sunoco in Oklahoma which are the buyers which then send oil to refineries. They receive Kansas common pricing and Oklahoma spot prices for their oil. The Company has started commercial sales of natural gas at their Yale Prospect through their connection to nearby pipeline infrastructure. They sell natural gas through the pipeline to DCP Midstream, LP of Tulsa, Oklahoma and receive a premium to the NYMEX spot natural gas prices due to the higher BTU content of the gas produced.
In May, American Petro-Hunter announced that the SOM-1H horizontal well at the Company's South Oklahoma Project reached T.D (total depth) after successfully drilling the planned 2,500+ foot lateral arm into the Mississippi Lime reservoir. The SOM 1-H is the first well drilled on the Company's South Oklahoma Project that encompasses approximately 5,000 gross acres of leases underlain by the thick Mississippi Lime in an area that has enjoyed a well-documented and lengthy period of historic production from vertical Mississippian wells.
American Petro-Hunter, Inc. (AAPH), closed Wednesday's trading session at $0.22, down 2.27%, on 13,150 volume with 6 trades. The average volume for the last 60 days is 74,988. The 52-week low/high is $0.14/$0.62.
Newmac Resources, Inc. (NER.V)
We are highlighting Newmac Resources, Inc. (NER:CA) today, here at the QualityStocks Daily Newsletter.
Newmac Resources, Inc. is a junior exploration company that lists on the TSX Venture Exchange. The Company engages in the acquisition, exploration, and development of mineral properties in Canada. Newmac explores for copper, gold, silver, molybdenum, and tungsten ores. Incorporated in 2003, Newmac Resources has their headquarters in Vancouver, British Columbia.
The Company focuses on the exploration and development of the Crazy Fox property, the Moira property, the Raft property, the River property, the Garnet property, the Lynx property, and the Molybar property located in British Columbia. The Crazy Fox Moybdenum-Tungsten property is approximately 100 km north of Kamloops, British Columbia, and on the eastern edge of the caribou plateau approximately 20 km NW of Little Fort.
The Raft property is located 35 kms northeast of Clearwater, British Columbia. The property covers an area of approximately 139 square kilometers (13,881 hectares) in size. Since optioning the property in May 2010, Newmac Resources has completed a soil sampling program and a VLF-EM and magnetic survey on a portion of the property. After these programs were completed, the Company followed up with 5 trenches.
Newmac views the Ready Raft property as an excellent target for intrusion related gold mineralization because of several tungsten skarns in the area, anomalous gold, tungsten, molybdenum, arsenic in stream sediments, and Shuswap metamorphic terrain intruded by Cretaceous granites, which have been recognized as causing the mineralization. The Company has the right to earn a 100 percent interest in the Ready Mix claims (part of the Raft Property).
In December 2011, Newmac Resources announced that they received a National Instrument 43-101 compliant report on the Crazy Fox property. The authors of this Technical Report, E. D. Harrington, PGeo and T. H. Carpenter, PGeo, of Discovery Consultants were requested to undertake an independent review of all available geological, geochemical and geophysical reports and data on the Crazy Fox Property.
Newmac Resources, Inc. (NER.V), closed Wednesday at $0.65, up 30.00%, on 4,735 volume. The 52-week low/high is $0.50/$1.60.
Orgenesis, Inc. (ORGS)
Earlier, pastwellness.com reported on Orgenesis, Inc. (ORGS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Orgenesis, Inc. is a development stage company with a novel therapeutic approach in the treatment of diabetes. This is through correcting malfunctioning organs with new functional tissues created from the patient's own existing organs. The Company employs a molecular and cellular approach directed at converting liver cells into functional insulin-producing cells as a treatment for diabetes. This new therapeutic approach goes by the name Autologous Insulin Producing (AIP) cell transplantation. Orgenesis lists on the OTC Bulletin Board. The Company has their headquarters in White Plains, New York.
Orgenesis believes that converting the diabetic patient's own tissue into insulin-producing cells overcomes the problem of donor shortage and removes the risk of transplant rejection. The Company has manifested promising results in in-vitro and in-vivo studies using human liver tissues. Orgenesis has designed an efficient and clear work-plan to initiate clinical testing allowing them to launch Phase I clinical trials following FDA guidelines followed by the launch of Phase II clinical trials.
The basis of the Company's technology is on IP licensed from Israel's acclaimed Sheba Medical Center. This portfolio is based on the groundbreaking work and two decades of research by the world-renowned researcher, Prof. Sarah Ferber. Prof. Ferber is the head of the endocrine research unit at Sheba Medical Center. Orgenesis' technology has been developed following extensive animal safety testing and the research has matured to the stage of clinical development. More than 50 centers worldwide are highly qualified for Pancreatic Islet transplantation. It is Orgenesis' intention to work closely with such leading centers in order to enable Autologous Insulin Producing (AIP) cell transplantation as a therapeutic approach in the treatment of diabetes at those centers.
Recently, Orgenesis announced and welcomed the appointment of Ms. Etti Hanochi, CPA as the Company's newest addition to the Board of Directors and member of the compensation committee. Ms. Hanochi is a Partner at Nextage Ltd. (Israel) a privately held global financial services organization.
Orgenesis, Inc. (ORGS), closed Wednesday's trading session at $0.70, up 7.69%, on 20.037 volume with 9 trades. The average volume for the last 60 days is 13,480. The 52-week low/high is $0.01/$1.66.
Voice Assist, Inc. (VSST)
OTCPicks reported recently on Voice Assist, Inc. (VSST), Bull in Advantage, Buzz Stocks did earlier, and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Trading on the OTC Bulletin Board, Voice Assist, Inc. is an award-winning provider of mobile speech solutions. The design of these is to be used from any phone and eliminates the need to press buttons on smartphones, tablet PCs or other network-connected devices. Voice Assist also offers their hands-free safe driving application and CRM-by-voice applications direct to the public and/or through resellers and private label OEM relationships. Voice Assist has their corporate headquarters in Lake Forest, California.
Voice Assist is a fast and safe way to make calls, manage e-mails and send text messages by voice commands over the phone. A user calls a Voice Assist access number and says what they want to do. Mobile developers and cloud-based service providers can leverage Voice Assist's platform to provide voice access to any application through its rapid application development environment and mobile widgets making it easy to add a powerful voice interface to almost any application.
Voice Assist combines the latest speech technology with internet-based information and a world-class telecommunications network. With a speech driven user interface, Voice Assist is ideally suited for a mobile hands busy environment, like in the car, or on the go.
Recently, Voice Assist announced that they closed a private placement yielding gross proceeds of $800,000. The proceeds are to accelerate market penetration and the technology growth of their award-winning speech platform and services.
Last week, Voice Assist announced the launch of their Live Assist™ personal concierge service. Live Assist is available 24 hours a day, 7 days a week to provide answers and assistance to mobile subscribers, from any phone, anywhere. Live Assist is helpful while on-the-go providing a wealth of valuable information.
Live Assist works on 100 percent of all mobile phones and connects mobile subscribers to their own live personal concierge for fast, accurate and convenient assistance. Live Assist is a cloud-based service that does not require a download to one's phone. Live Assist pricing is $10.00 per month, which includes 10 calls per month and unlimited emergency assistance calls.
Voice Assist, Inc. (VSST), closed Wednesday's session at $0.29, even with yesterday’s close, on 41,100 volume with 12 trades. The average volume for the last 60 days is 73,564. The 52-week low/high is $0.06/$1.70.
Generex Biotechnology Corp. (GNBT)
OTCPicks, PennyTrader Publisher, and Greenbackers reported earlier on Generex Biotechnology Corp. (GNBT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Generex Biotechnology Corp. engages in the research, development, and commercialization of drug delivery systems and technologies. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). Their proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device. Generex Biotechnology has their headquarters in Toronto, Ontario.
RapidMist™ is an advanced buccal drug delivery technology. It consists of a proprietary formulation and a proprietary device design that is able to deliver drugs through the buccal mucosa safely, eliminating the pain from and need for multiple injections. RapidMist™ has been shown to have a rapid onset of action with no lung deposition, precise dosage control, easy use and handling, and improved patient compliance.
Antigen Express, Inc. is a wholly owned subsidiary of the Company. The core platform technologies of Antigen Express consist of immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T-helper stimulation technologies in immunotherapy. One technology focuses on modification of peptides with Ii-Key to increase potency. A second relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells.
Last week, Generex announced publication of an abstract demonstrating a more broad and robust immunological response in AE37 treated patients with prostate cancer than previously suspected. The AE37 immunotherapeutic cancer vaccine, currently in Phase II clinical trials in patients with breast cancer, is undergoing development by Generex' wholly owned subsidiary Antigen Express. The abstract is published in conjunction with the Annual Meeting of the American Society of Clinical Oncology (ASCO) as part of the Journal of Clinical Oncology (J Clin Oncol 30, 2012 (suppl; abstr e15125).
Today, Generex Biotechnology announced the results of the Company's annual meeting of stockholders held on June 19, 2012. At the annual meeting of stockholders, the following directors were elected to serve on the Board of Directors until the next annual meeting of stockholders: John Barratt, Brian McGee, Nola Masterson, Mark Fletcher, Dr. James H. Anderson, Jr., MD, and Dr. Eric Von Hofe, PhD. Stockholders also ratified the appointment of MSCM LLP as the Company's independent registered public accounting firm for the year ending July 31, 2012.
Additionally, Generex announced that Dr. James T. Symanowski, PhD has joined the Antigen Express AE37 breast cancer vaccine working group as a consultant oncology biostatistician. This is to provide advice and assistance in respect of the on-going Phase II clinical trial of the vaccine and the transition into a pivotal Phase III trial.
Generex Biotechnology Corp. (GNBT), closed Wednesday's trading session at $0.09, down 8.00%, on 2,945,771 volume with 142 trades. The average volume for the last 60 days is 642,546. The 52-week low/high is $0.07/$0.27.
Great American Group, LLC (GAMR)
Today we are reporting on Great American Group, LLC (GAMR), here at the QualityStocks Daily Newsletter.
Great American Group, LLC is a leading provider of asset disposition solutions and valuation and appraisal services. These solutions and services are to a broad spectrum of industrial and retail clients, as well as lenders, capital providers, private equity investors and professional service firms. Great American Group has partnered with businesses worldwide in effectively appraising and divesting assets with the main objective of maximizing value. The Company has offices in Atlanta, Boston, Charlotte, North Carolina, Chicago, Dallas, London, Los Angeles, New York and San Francisco.
Great American Group's services include asset dispositions, auctions, appraisal and valuation services, and real estate services. They also include evaluation of intellectual property and other intangible assets, loan sale advisors, and home auctions. The Company's Liquidation and Auction Solutions segment assists clients in maximizing return and recovery rates by way of the disposition of various assets. These include multi-location retail inventory, wholesale inventory, trade fixtures, machinery and equipment, intellectual property, and real property. This segment also provides merger and acquisition due diligence services. The Company's valuation and appraisal services segment provides clients with independent appraisals in connection with asset based loans, acquisitions, divestitures, and other business needs; and reverse logistics and real estate appraisal services.
The Company's GA Keen Realty Advisors segment provides real estate analysis, valuation and strategic planning services, brokerage, auction services, lease restructuring services, real estate capital market services, and mergers and acquisitions related services to property owners, tenants, secured and unsecured creditors, attorneys, and financial advisors.
At the end of May, Great American Group announced that GA Keen Realty Advisors is marketing the assignment of the lease on the former Esprit retail location on 34th Street directly across from the Empire State Building. The site (located at 21 West 34th St.,) is 17,741-square-feet in size. It provides 6,451 square feet of retail space on the ground floor, 5,100 square feet on the second floor and 6,190 square feet in the basement. Other nearby retailers include Aeropostale, Aldo, Banana Republic, Fossil, Express, Gap, H&M, Men's Wearhouse, Steve Madden, and Victoria's Secret.
Great American Group, LLC (GAMR), closed today's session at $0.29, down 3.65%, on 81,280 volume with 17 trades. The average volume for the last 60 days is 41,736. The 52-week low/high is $0.05/$0.45.
North Springs Resources Corp. (NSRS)
TerrificPennyStocks, JediPennyStocks, and Pumps and Dumps reported this month on North Springs Resources Corp. (HPGS), Orbit Stocks, EpicVIP Group, and Epic Stock Picks did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
North Springs Resources Corp. focuses on the evaluation, acquisition, exploration, and development of mineral resource properties. The Company is a Nevada based mineral exploration enterprise concentrating on discovering and advancing precious metal properties in Nevada and Arizona, and elsewhere. A skilled and experienced management team and independent consulting geologists with many years of experience lead the Company. North Springs Resources' shares trade on the OTCBB; the Company has their headquarters in Reno, Nevada.
The Company is always looking to add to their asset property base. This is by acquiring additional leases, and entering into Joint Venture agreements and partnerships that they believe will add to overall shareholder value. Their projects include the Edum Banso Gold Project (Ghana). The Edum Banso Gold Project concession covers 20.60 km2 (5,100 acres) located approximately 35 km (21 miles) northwest of city of Takoradi in the southeastern portion of Ghana's historic Ashanti Gold Belt. The concession is less than one mile from the border of the HBB Father Brown/Adoikrom open pit gold deposits currently undergoing mining by Golden Star Resources.
North Springs also has their Goldstar/One Armed Joe (Arizona) project. The Goldstar Property consists of 9,000 feet of gold bearing quartz veins in two zones (Goldstar: 6,000 feet and One Arm Joe: 3,000 feet) over 9 claim blocks totaling 180 acres. In addition, the Company has their Imperial Project (Nevada). The Imperial Gold/Silver Property consists of 24 unpatented mineral claims in Nevada covering approximately 480 acres between the Montezuma Range to the northeast and the Silver Peak Range to the southwest.
Furthermore, the Company has their North Springs Property (Nevada). The North Springs Gold Property is approximately 8 miles northwest of the town of Silver Peak, Nevada. The Silver Peak Mountain Range lies in the southern reaches of the Great Basin, within the Walker Lane structural corridor. The North Springs Gold Property consists of approximately 16 unpatented federal lode mining claims that cover two separate areas, the Roadrunner Block and the Coyote Summit Block, and total approximately 320 acres.
This past March, North Springs Resources announced that they received the final draft of a positive geological review regarding the Company's earlier acquired 10 percent interest in an option on various producing gold and silver properties in Chihuahua, Mexico. The Company initiated geological review was completed as part of the acquisition due diligence process and was conducted by an independent accredited geologist licensed by the Mexican Mining Authority. The independent review has validated prior representations made by Hyperion Management Mining S.A. regarding the combined inferred reserve estimates for the properties.
North Springs Resources Corp. (NSRS), closed Wednesday's trading session at $0.03, up 11.11%, on 362,701 volume with 35 trades. The average volume for the last 60 days is 1,324,786. The 52-week low/high is $0.007/$1.72.
Comprehensive Care Corp. (CHCR)
ItsAllBull.net, Penny Stock Farmer, Melburn Richman Advisory, Picks That Move, HyperGrowthStock, Penny Stock Ryder, and Pinksheet Stocks reported previously on Comprehensive Care Corp. (CHCR), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Established in 1969, Comprehensive Care Corp. (CompCare) provides behavioral health, substance abuse, and psychotropic pharmacy management services for managed care companies throughout the United States and Puerto Rico. Incorporated in the state of Delaware, the Company focuses on personalized attention, flexibility, and a commitment to high-quality services and innovative approaches to behavioral health that address the specific needs of clients and changing healthcare industry demands. CompCare has their headquarters in Tampa, Florida. The Company's shares trade on the OTC Bulletin Board.
The Company is a managed behavioral healthcare organization. They administer behavioral health and substance abuse benefits for a variety of clients. These clients include employer groups, HMOs, PPOs, and state and local criminal justice programs. CompCare serves members in the commercial and public sector. This includes Medicaid and Medicare, Employer groups in diverse industries, Health Plans, as well as Government Employee Plans. CompCare achieved Full NCQA Accreditation of all product lines in 2005. Accreditation occurs every three years.
The Company offers a wide spectrum of services such as Managed Behavioral Health Care Programs (Public and Commercial Sectors), Integrated Disease Management, Managed Psychopharmacy Programs, and Validated Financial Forecasting. In addition, they offer Employee Assistance Programs and Worklife Dependent Care Services, Behavioral Healthcare for Criminal Justice and Juvenile Justice Programs, and Managed Systems for the Child Welfare and Developmentally Disabled Populations. In addition to their traditional, high-quality, integrated behavioral health program, they offer innovative solutions in Substance Abuse Disease Management and Integrated Health Care Management supported by Pharmacy Data Analysis.
At the end of May, CompCare announced that the Company has undertaken significant steps that they believe will further reduce their overhead as part of a continuing program to increase margins and obtain sustainable profitability.
Mr. Robert Kulbick, President, said, "Starting the process in the first quarter of this year, the Company thus far has reduced its monthly general and administrative expenses by approximately 12 percent. We expect to be able to implement further cost-saving measures over the coming months."
Comprehensive Care Corp. (CHCR), closed Wednesday's session at $0.15, up 18.10%, on 7,400 volume with 10 trades. The average volume for the last 60 days is 19,361. The 52-week low/high is $0.10/$0.35.
SilverSun Technologies, Inc. (SSNT)
The QualityStocks Daily Newsletter would like to spotlight SilverSun Technologies, Inc. (SSNT). Today, SilverSun Technologies, Inc. closed trading at $0.29, up 70.59%, on 653 volume with 2 trades. The stock’s average daily volume over the past 60 days is 21,712, and its 52-week low/high is $0.005/$0.51.
SilverSun Technologies, Inc. (SSNT), via wholly-owned subsidiary SWK Technologies, is a premier total solutions provider specializing in business software for manufacturers and distributors. Established in 1988, the company focuses on meeting the needs of small-sized and mid-sized businesses ("SMB" marketplace) with accounting and business management products, including SilverSun's own proprietary software. The company also offers its own cloud-based solutions and provides network services (network configuration, data backup, 24/7 remote monitoring, etc.) to its clients.
SilverSun distinguishes itself from traditional software resellers by offering a wide range of value-added services, consisting primarily of programming, training, technical support, and other consulting and professional services. The company also provides software customization, data migration, business consulting, and implementation assistance for complex design environments. Currently, the company has over 1,000 active customers.
In addition to driving organic growth, SilverSun's aggressive growth strategy includes acquiring firms in the extensive and expanding SMB marketplace to create substantial value for its shareholders, employees, and partners. SilverSun aims to leverage SWK Technologies as a platform to roll up and aggregate the best and brightest ERP resellers, as well as other software companies with proprietary products that serve the SMB marketplace. The company's most recent acquisition was in January 2012.
In 2011, SilverSun increased sales 40% over the previous year and strengthened its balance sheet through the elimination of all outstanding debt. With organic sales accelerating, significant debt reduction, and great depth of expertise and resources, SilverSun is well positioned to become a dominant player in the growing business software marketplace. Disclaimer
SilverSun Technologies, Inc. Blog
SilverSun Technologies, Inc. News:
SilverSun Technologies Completes Asset Purchase of Chicago-Based Hightower
SilverSun Technologies Completes Asset Purchase of Micro-Point
SilverSun Technologies Reports First Quarter 2012 Results
USA Recycling Industries, Inc. (USRI)
The QualityStocks Daily Newsletter would like to spotlight USA Recycling Industries, Inc. (USRI). Today, USA Recycling Industries, Inc. closed trading at $0.12, up 23.08%. on 4,150 volume with 2 trades The stock’s average daily volume over the past 60 days is 17,814, and its 52-week low/high is $0.03/$0.14.
USA Recycling Industries, Inc. (USRI) is a mid-market recyclable waste collection & disposal service, providing specialty recycling programs to commercial & industrial customers throughout North America. Operating through multiple company-owned & partnership recycling centers, the company primarily targets growth opportunities in the $75 billion global scrap metals market.
USA Recycling has operated since its inception in 2000, and its largest operating subsidiary, Scrap USA, since 2007 has been focused on and successful in servicing the automotive service center industry. It currently provides specialty recycling programs to more than 5,000 automotive service center locations operated by some of the most recognizable names in that retail category.
With a well-established national footprint, the company is now integrating other ancillary services such as the collection & disposal of other recyclable waste streams. USA Recycling has also opened the door to franchising opportunities and recently signed a proprietary revenue sharing agreement with Recycling Franchisors, Inc. Other initiatives to drive growth and boost prominence include the launch of a new website and relocation of executive offices.
USA Recycling has successfully contracted automotive waste-generators for collection & disposal services, selling the processed recyclable materials to end-user-consumers through the company's trading operations with offices in North America, India, and the United Arab Emirates. The company's primary aim is to maximize shareholder value while providing the highest level of quality waste collection & disposal services to its customers, ensuring its collected debris remain free of any U.S. landfills. Disclaimer
USA Recycling Industries, Inc. Company Blog
USA Recycling Industries, Inc. News:
USA Recycling Industries Enters Oil Filter Collection and Disposal Services Agreement With Redwood Recycling
USA Recycling Industries Signs Letter of Intent to Expand Used Oil Filter Recycling Operations
USA Recycling Industries, Inc. (USRI) Announces Engagement of QualityStocks Investor Relations Services
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.41, up 2.50%, on 508,269 volume with 56 trades. The stock’s average daily volume over the past 60 days is 199,409, and its 52-week low/high is $0.21/$1.15.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Scientists Create New Protein-Based Stem Cell Technology
International Stem Cell Corporation Announces Marketing Plans for Its Wholly Owned Subsidiary Lifeline Skin Care
International Stem Cell Corp Announces First Quarter 2012 Financial Results and Business Highlights
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $1.61, off by 5.42%, on 5,100 volume with 6 trades. The stock’s average daily volume over the past 60 days is 6,288, and its 52-week low/high is $1.02/$1.87.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise to Present at the Inaugural Marcum MicroCap Conference on June 20th in New York City
GlobalWise Signs Channel Sales Partnership With Sycle.net
GlobalWise Announces Success of Partner Advisory Board Event
IMAGINiT Technologies, a division of Rand Worldwide, Inc., a global provider of technology solutions to organizations with engineering design and information technology requirements, is one of the first partners to receive the exclusive Autodesk PLM 360 Specialization designation in both the United States and Canada.
IMAGINiT underwent and passed rigorous product, technical and implementation training, and testing, which authorized the company’s team to sell, implement, and launch its clients’ Autodesk PLM 360 solutions.
“With two decades of experience in data management and business process optimization and now receiving the Autodesk PLM 360 Specialization designation, IMAGINiT is qualified to analyze their clients’ business processes and automate them utilizing the Autodesk PLM 360 platform,” Callan Carpenter, vice president of Global Services, Autodesk stated in the press release.
Autodesk’s cloud-based PLM 360 solution is more flexible than traditional PLM solutions and creates a platform that eliminates the challenges related to IT infrastructure and hardware requirements.
“There’s an entire segment of businesses that have been waiting for a robust yet flexible PLM solution that won’t break the bank,” said Bill Zavadil, senior vice president of IMAGINiT Worldwide Services at IMAGINiT Technologies. “With more than 20 years of experience assisting organizations to effectively integrate PLM solutions across their business, we’re well positioned to help our clients recognize the full potential of the Autodesk PLM solutions.”
For more information visit www.rand.com
AcelRx Pharmaceuticals announced today that the U.S. Patent and Trademark Office (USPTO) has issued AcelRx Patent Number 8,202,535, titled “Small-Volume Oral Transmucosal Dosage Forms.” The patent details a method for treating pain by administering a small-volume solid tablet that contains sufentanil by adhering to the oral mucosa. The patent will give intellectual property protection for sufentanil NanoTab-based products until late 2030.
This newly issued patent is an important addition to AcelRx Pharmaceuticals’ patent portfolio, strengthening the company’s ability to protect its proprietary technology in the U.S. The company remains dedicated to the continued expansion of its patent portfolio as it establishes the safety and efficacy profile of the ARX-01 Sufentanil NanoTab PCA System, the first phase 3 data for which is being expected later this year. The system, AcelRx’s lead product candidate, is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia, which has been shown to cause harm to patients following surgery due to the side-effects of morphine, the invasive IV route of delivery, and the inherent potential for programming and delivery errors related to the complexity of infusion pumps.
This newly issued method patent is the first patent issued by the USPTO in relation to sublingual sufentanil NanoTabs. Exclusively owned by AcelRx, the patent provides domestic protection for each of the company’s four development programs. Patent 8,202,535 covers the company’s proprietary NanoTab technology for delivering sufentanil with claims to elements of a pain treatment method by administering a small volume (less than 15mcl) substantially homogenous solid tablet that contains the active ingredient sufentanil to the oral mucosa of a subject, simultaneously generating a minimal saliva response and delivering most of the drug through the transmucosal route, resulting in pharmacokinetics.
AcelRx additionally holds a European patent EP2114383B1, covering small-volume NanoTab dosage forms for transmucosal administration that contains the opioid sufentanil. This European patent covers portions of the company’s dispensing technology and also provides patent protection of particular pharmacokinetic parameters derived from sublingual administration using the NanoTab technology. With more than 70 patent applications currently pending throughout the world, AcelRx continues to file additional new patent applications to further solidify its market exclusivity.
AcelRx Pharmaceuticals is a specialty pharmaceutical company engaged in developing and commercializing innovative therapies for treating acute and breakthrough pain.
For more information, visit the company’s Web site at www.acelrx.com
Pershing Gold, the precious mineral developer with an established acreage footprint in Pershing County, at the heart of mining-friendly Nevada, which has the second largest gold reserves on earth (only South Africa has more and it’s far easier to do business in NV), reported securing a huge private placement deal today, totaling $4M in gross proceeds.
The deal has two primary components:
• A purchase by Coeur d’Alene Mines Corp. of 10.937M shares of PGLC at $0.32/share
• And a purchase by existing PGLC shareholder, Dr. Phillip Frost, in conjunction with the Coeur purchase and executed via Frost Gamma Investment Trust (FGIT), of another 1.5625M shares of PGLC common stock under similar material terms and conditions
As a result of the transaction, Coeur and FGIT will both obtain participatory rights in any future financing arrangements (so as to maintain their relevant ownership interests).
Executive Chairman and CEO of PGLC, Stephen Alfers, emphasized the logistical synergy and hailed this really encouraging private placement by major mineral sector player Coeur as a clear sign of the future of Pershing’s Relief Canyon properties. Alfers indicated that the proceeds would be directly applied to development of the site and that particular attention would be paid to the Pershing Packard exploration.
Looking at the localized topology, it is hard to miss the alignment of the noted geophysical anomalies, the Pershing Packard project, and then Coeur’s Nevada Packard Mine further north along the western side of range. The pit for the Relief Canyon Mine is at the base of the range further south and the on-site processing facility, just west of the pit, already has many of the essential elements to support expansion of prospective acreage to the north (like Packard) and south (five heap leach pads, two solution ponds, and an ADR solution processing circuit). With historic production over 110k ounces, excellent mineralization targets to go after, and extant processing capacity already on the mill site claims, PGLC is now well-equipped with the CAPEX muscle to get some serious work done.
Stretching out over 24k acres on a mix of private lands and unpatented mining claims, the entire PGLC acreage footprint encompasses some very interesting geology, much of it analogous to Coeur’s position. Control of the Relief Canyon Mine property and its surrounding lands, in conjunction with the owned claims and untested targets mentioned, as well as additional targets like the southerly Pershing Pass area, offer PGLC a rich menu of development choices.
Shareholders are really pleased by PGLC’s ability to nail down this kind of private placement and investors in general are starting to see the potential of the company’s emphasis on under-explored Nevada mineralization.
Despite near-term price pullbacks in gold as investors settle around no new easing from the federal reserve, we are over the $1550 support level today at just over $1600 an ounce (1-year low of $1486, 5-year low of $641) as the sovereign debt crisis, especially in Europe, simply will not go away. Tack on the obvious move by central banks around the world to increase holdings of gold by multiples of two to three; pulling more tons of supply off the market than ever before, it is a very good environment for PGLC to be developing domestic precious metals.
For more information on the deal announced today, or to learn more about Pershing Gold Corp., please visit the company’s website at:www.PershingGold.com
Yesterday, Satcon Technology, a leader in providing utility-scale power conversion solutions for the renewable energy market, announced it has been selected by Southern Sky Renewable Energy and Gemma Renewable Power to supply 5 MW of its Equinox solution.
Based in Boston, Mass., Southern Sky Renewable Energy LLC is a utility-scale solar PV developer. Gamma Renewable Power is a nationally recognized engineering, procurement, and construction (EPC) organization specializing in the construction of renewable energy projects, and the company is presently constructing both wind and solar projects in western Illinois, Massachusetts, and central Pennsylvania.
Equinox is Satcon’s next-generation solar inverter, offering 98.5% peak efficiency. The solution is built on Satcon’s industry-leading PowerGate Plus family, which consists of the most widely deployed large-scale PV inverter solutions in the world. Equinox enhances system-wide energy harvest and solar plant yield, enabling the highest return on investment in the industry. The solution’s advanced utility-ready features allow remote control of real and reactive power, low-voltage ride-through and power factor control. Equinox also supports fast communications, allowing the solution to be integrated easily into SCADA systems through standardized communication interfaces.
Satcon is powering many of the largest and most advanced utility-scale solar farms on earth, with more than 2.5 GW of solar inverter solutions shipped to date. Equinox solutions all include EDGE Adaptive Control Architecture (ACA), which enables instant voltage stabilization, frequency control, and dynamic grid support. EDGE ACA also secures the continuous operation of the PV plant in case of dynamic ground faults, achieving the performance guidelines implemented by the German Association of Energy and Water Industries (BDEW 2008 Grid Connection Standard).
The new site, located in Massachusetts, will be the largest ground mount PV installation on a landfill in that state. The site is expected to be energized in the first half of 2012.
Satcon Technology Corporation is a leader in providing utility-scale power conversion solutions for the renewable energy market. The company enables the industry’s most advanced, reliable, and proven clean-energy alternatives. For almost three decades, Satcon has designed and delivered cutting-edge, efficient energy systems for solar photovoltaic, stationary fuel cells and energy storage systems.
For more information, visit the company’s Web site at www.Satcon.com
Today's Top 3
The QualityStocks Public Company Sponsor News